Sequoia Capital

Sequoia Capital is a prominent venture capital firm founded in 1972 and based in Menlo Park, California. The firm specializes in investing across various stages of startups, including seed, early, and growth stages, and focuses on sectors such as technology, healthcare, financial services, internet, and mobile. Sequoia typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $100 million in growth investments. The firm operates globally, with significant activities in regions like Israel, China, and India, where it partners with dynamic founders to build successful companies. Sequoia's extensive portfolio includes notable firms and offers valuable insights and resources, benefiting from decades of experience in the venture capital landscape.

Gian Adhitya

Associate

Rohit Agarwal

Investment Analyst

Akshay Agarwal

Associate

Suraj Agarwalla

Associate

Ashish Agrawal

Managing Director

Abheek Anand

Managing Director

Rajan Anandan

Managing Director

Bogomil Balkansky

Partner

Julien Bek

Partner

Mohit Bhatnagar

Managing Director

Anas Biad

Partner

Isaiah Boone

Partner

Roelof Botha

Executive

Jaime Bott

Partner of Human Capital

Romie Boyd

Partner

David Cahn

Partner

Anni Cai

Associate

Josephine Chen

Partner

Sakshi Chopra

Principal

William Coughran Ph.D

Partner

Charlie Curnin

Partner

James Flynn

Partner

Jim Goetz

Partner

Chinmaya Golecha

VP

Ajey Gore

Operating Partner of Technology

Pat Grady

Partner

Irwin R. Gross

MD

Ravi Gupta

Partner

Rachit Gupta

Associate

Kriti Gupta

Associate

Dannie Herzberg

Partner

Sonya Huang

Partner

Augustus Ilag

Associate

SK Jain

Co-Founderand MD

Amit Jain

Managing Director

Steve Yue Ji

Partner

Liu Jiang

Partner

Sandeep Kapoor

CLO and Compliance Officer, India

Aakash Kapoor

VP

Pieter Kemps

Principal

Kais Khimji

Partner

Marie Klemchuk

Global CFO

Shailesh Lakhani

Principal

Jess Lee

Partner

Doug Leone

Partner

Alfred Lin

Partner

Junrui Lin

Partner and Co-Head

Luciana Lixandru

Partner

Cherry Lu

Partner

Patricia Ma

Director of People Operations

Shaun Maguire Ph.D

Partner

Nipun Mehra

VP and Investment Advisor

Cornelius Menke

Partner

Dean Meyer

Partner

Matthew Miller

Partner, Growth

Ishaan Mittal

Principal

Natalie Miyake

VP of Communications

Abhishek Mohan

Vice President

Michael Moritz

Managing Partner

Anirudh Bose Mullick

Head of Recruitment and VP

Shreyas Nair

Senior Associate

Kevin Pan

Managing Director

Prachi Pawar

Associate

Mayank Porwal

VP

Enita Pu

Partner

Amrut Rajkarne

Associate

GV Ravishankar

Managing Director

Andrew Reed

Partner

Lauren Reeder

Partner

Prasanna Rengarajan

Associate

George Robson

Partner

Anandamoy Roychowdhary

Principal

Anjana Sasidharan

Principal

R. Bryan Schreier

Partner

Harshjit Sethi

Principal

Tejeshwi Sharma

Managing Director

Navendu Sharma

Associate

Neil Shen

Managing Partner

Bharat Singh

Chief Financial Officer

Thomas Stephenson

Partner

Amy Sun

Partner

Johan Surani

vice_president

Ian Taylor

Head of scouts

Shraeyansh Thakur

Investment Analyst

Mike Vernal

Partner

Jeffrey Wang

Managing Partner & Portfolio Manager

Shenya Wang

Associate

Cen Wang

Partner, China

Klaus Wang

VP

Past deals in Shanghai

Sycoretec

Seed Round in 2023
Zhongke Haishi is a high-tech enterprise specializing in the research and development, production and sales of new materials and their application in the field of temperature-regulating functional textiles.

Deep Intelligent Control

Series A in 2023
Deep Intelligent Control is a service provider for digital intelligence innovation and energy conservation. They conduct research and develop a new generation of products and technologies for energy efficiency and Internet of Things (IoT) intelligent control, empowering the building and industrial energy-saving industries, realizing significant energy savings in electromechanical energy systems, and assisting businesses in becoming digitally intelligent, resulting in a 2% reduction in carbon emissions.

Lingyi Biology

Series A in 2023
Lingyi Bio is a rare disease animal model functional verification platform and gene therapy developer.

DeepLang AI

Venture Round in 2023
DeepLang AI aims to build an industrial-level Chinese information processing engine using a self-developed large-scale model.

Bioyond Tech

Series A in 2023
Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

PhaBuilder

Series A in 2023
PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".

Carbonstop

Series B in 2022
Carbonstop specializes in carbon emission management solutions, offering a comprehensive software platform designed to assist businesses in calculating, analyzing, managing, and reporting their carbon emissions. The company provides carbon accounting software that enables enterprises to effectively track and reduce their CO2 emissions. In addition to its software offerings, Carbonstop also delivers carbon management consulting and training services, helping organizations implement strategies to minimize their carbon footprint. Through these solutions, Carbonstop aims to support companies in their efforts to promote sustainability and reduce their environmental impact.

SiEngine Technology

Series A in 2022
SiEngine technology creates vehicle electronic chips.

Spectrum Medical

Series A in 2022
Spectrum Medical is a clinical mass spectrometry product platform that promotes clinical mass spectrometry detection technology to the general public. It has an experienced research and development, operations, and sales team, a standardized GMP production workshop, extensive experience in laboratory construction, and a mature laboratory management system. It provides with complete supporting kits in addition to mastering the core mass spectrometry hardware manufacturing technology and equipment integration development capabilities (maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, etc.).

Mech-Mind

Series C in 2022
Mech-Mind Robotics Technologies Ltd. designs, develops, and sells hardware and software solutions for logistics industry. The company manufactures smart cameras, such as Mech-Eye Smart Camera, Mech-Eye Broad Smart Camera, and Mech-Eye Pro S Smart Camera for object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind Robotics Technologies Ltd. also develops software solution that allows robotic camera to recognize objects in different shapes and different sizes. In addition, the company also manufactures logistic parcels picking solution for logistic customers. Mech-Mind Robotics Technologies Ltd. was founded in 2016 and is based in Beijing, China with additional office in Munich, Germany and sale office in Shanghai, China.

HAI ROBOTICS

Series D in 2022
HAI ROBOTICS, founded in 2016 and based in Shenzhen, China, specializes in developing autonomous case-handling robotic systems for warehouse automation. The company offers a range of intelligent automation solutions, including a goods-to-person system, smart in-plant logistics, and multi-tier steel platform solutions, suitable for diverse operational scenarios. HAI ROBOTICS is a pioneer in the field, having launched its first autonomous case-handling robot, HAIPICK, in 2015. The HAIPICK system has demonstrated significant advantages, enhancing warehouse operational efficiency by three to four times and increasing storage density by 80% to 130%. The company is committed to research and development, holding numerous patents and continuously improving its products to meet the needs of a growing customer base, which includes major clients like DHL Supply Chain, BEST Supply Chain, and Philips. With the capability to deploy automation solutions within a week, HAI ROBOTICS aims to optimize warehousing operations through advanced robotics and artificial intelligence.

DigitAlp

Angel Round in 2022
DigitAlp is a scientific and technical innovation company devoted to increasing the value of clinical research by giving a fresh perspective-a one-stop digital solution for the whole clinical trial process centred on institutions. Their solution includes an institutional comprehensive management system, the trial electronic medical record system, the sponsor service system, and the subject recruitment and full-service system.

Yueer Gene

Series B in 2022
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.

NuProbe

Series B in 2022
NuProbe, Inc. is an early-stage molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and based in Cambridge, Massachusetts, with an additional office in Shanghai, China, the company has developed a unique platform utilizing genetic toehold probes for quantitative PCR (qPCR) mutation detection. This innovative probe technology offers a Sample-In Answer-Out (SIAO) solution that integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatics interpretations, streamlining the diagnostic process.

ProfoundBio

Series A in 2022
ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.

Supreium

Series A in 2022
Supreium develops die-casting computer-aided engineering (CAE) simulation software solutions. The company offers a software as a service (SaaS) based CAE platform for intelligent manufacturing services. It offers mold pouring row design, mold cooling design, injection process analysis, and mold thermal balance analysis; process design services, including gate design, runner design, parting line design, and cooling design services; automatic defect detection Sares-ADR through images scanning; CAE private deployment; and process consulting services. The company serves medical treatment, marine water conservancy, communications, and industrial clients. The company was founded in 2016 and is based in Beijing, China.

Full-Life Technologies

Series A in 2022
Full-Life Technologies Limited is a global company specializing in RadioTherapeutics, with its headquarters in Shanghai, China, and operations extending to Europe. The firm focuses on targeted cancer therapy services within the radiotherapy field, aiming to enhance treatment outcomes for cancer patients. Full-Life is dedicated to advancing nuclear medicine through innovative research in radiopharmaceuticals, which supports healthcare providers in delivering effective cancer treatments.

Arctic Hero Core

Venture Round in 2022
Arctic Hero Core is focused to reducing the design cycle and NRE cost of large-scale, high-performance chips through chip technology, as well as quickly realizing iterative upgrades and product function additions, with the goal of providing customers with low-cost and high-flexibility solutions ranging from algorithms to server clusters.

Sensors Data

Series D in 2022
Sensors was founded in 2015 by Sang Wenfeng, former technology manager at Baidu Inc's big data department. It currently provides big data analysis services for over 300 companies, including bike sharing company ofo, Chinese workout mobile app Keep, and video sharing and live streaming app Miaopai.

SelectDB

Angel Round in 2022
SelectDB is a cloud-native real-time data warehouse that serves as an easy-to-use, high-performance, and unified analytical database. SelectDB's features include user management and access control, data protection and recovery, and data governance for data democratization. SelectDB supports real-time, interactive, and batch data processing, as well as structured and semi-structured data types and federated querying with datalakes and databases.

J-Elephant

Angel Round in 2022
J-Elephant develops intelligent mobile robot products and industrial automation products. J-Elephant develops forklift AMR, providing flexible manufacturing internal logistics solutions for clients in the manufacturing industry.

Neptune Robotics

Series A in 2022
Neptune Robotics develops and manufactures underwater drones designed for enterprises in the maritime industry. Its underwater drones reduce the spread of invasive species in the ocean and also include filtration and debris collection systems designed to clean up oceans, enabling the reduction of waste in the oceans and improve ocean ecosystems.

KAWO

Series A in 2022
KAWO connects teams across the globe providing data insights, greater transparency, and increased efficiency. We help international brands in China be more authentic and consistent on social media. Founded in 2013, KAWO’s experienced team is focused on delivering high-quality solutions allowing our clients to iterate fast in China’s rapidly changing social landscape. 科握将分布在全球的工作团队连接在一起,提供市场数据解读,增强流程透明化,提高团队效率。我们帮助国际品牌在中国树立更可靠的品牌形象并与其全球策略保持一致。 科握成立于2013年,我们富有经验的团队始终关注于提供高质量的解决方案,帮助我们的客户在快速变化的中国社媒营销市场中脱颖而出。

Xuanxing Technology

Angel Round in 2022
Xuanxing Technology provides industry's first execution navigation platform, through leading process mining and ultra-automation technology, improves the quality and efficiency of the core business processes of enterprises.

Exway

Series A in 2022
Exway manufactures customized smart vehicles for short trips for users, as well as high-end electric skateboards that combine modern technology and traditional craftsmanship. They also offer skateboard accessories such as apparel, protection gears and more.

Obsbot

Series B in 2022
A Smart Hardware Company based in Shenzhen,China.

Bench3D

Angel Round in 2022
Bench3D is a developer of 3D modeling software that focuses on enhancing the product development process through improved collaboration. The company offers a software-as-a-service (SaaS) platform that creates a shared working environment for engineers, designers, project managers, clients, and suppliers. This collaborative space allows users to exchange ideas, review CAD models, and make informed decisions, thereby streamlining workflows and facilitating efficient remote work. By bringing all stakeholders together around the same model, Bench3D aims to accelerate the development cycle and enhance productivity in design and engineering projects.

Xmov

Series B in 2022
Xmov is an AI company focusing on computer vision and computer graphics.

Yige Cloud Technology

Seed Round in 2022
Yige Cloud is a zero-trust enterprise network security solution provider. The company SASE serves network and security capabilities and integrates them into a cloud-native service platform to provide integrated network and security functions, realize threat detection and fine-grained access control across the enterprise, and ensure user experience and security when accessing applications. It provides integrated security services (such as threat prevention, web filtering, sandboxing, DNS security, data leakage prevention, and next-generation firewall policies), ensuring zero-trust access to the network.

Fabrie

Seed Round in 2022
Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.

Alpha Cen

Seed Round in 2022
Alpha Cen is a developer of wafer-level metasurface light control chips and modules. It offers a semiconductor IC-compatible process to integrate micro-nano optical metasurfaces with circuits, light sources, and photodetectors.

XVERSE

Series A in 2022
XVERSE is a technology company platform that develops 3D user-generated content. It aims to become one of the operating systems (OS) of the true Internet and one of the important content providers. The company is located in Shenzhen, China.

Lianyuan Intelligence

Series B in 2022
Shanghai Lianyuan Intelligent is an innovative energy Internet comprehensive value-added service provider jointly invested by the world's leading new energy companies and executives of the world's top 500 power industry and consulting companies.

With

Angel Round in 2022
With creates a warm voice companion community. It is a community app that integrates functions such as voice mic interaction, voice radio, dynamic circles, theme chat, and covers emotional radio, music cover, dubbing Pia drama, and other voice content.

XISOFT

Series B in 2022
Shanghai Xisoft Technology Co., Ltd. develops mobile applications and online solutions for hospital operation management. Its solutions include Xisoft Hospital Operation Management System (HRP), an information sharing systemic hospital resource management platform that supports the overall operation and management of the hospital; Xiaoxi Handheld HRP, a mobile application that integrates hospital functions, such as address book, salary query, public holiday query, project management, mobile reimbursement, and conference management; and Xiyun Platform, which aggregates common system data extraction, calculation, and release service interfaces of hospital operation and management. The company was founded in 2018 and is based in Shanghai, China with additional offices in Beijing, Harbin, Jinan, Chongqing, Hohhot, Yinchuan, Kunming, Shenyang, Dalian, and Changsha, China.

Xinlue Shuzhi

Series A in 2022
Xinlue Shuzhi provides digital operation solutions to consumers. Through scenarios that provide in-depth data analysis insights and a closed-loop business strategy that can be implemented and verified throughout the link, the company assists brands in acquiring and managing marketing and consumer data assets. Many well-known leading brands, including moody, WonderLab, Liran, Unilever, Nestle, GUCCI, Anta, and La Mer, used the products and services that Xinlue Shuzhi provided.

Inceptio Technology

Series B in 2022
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

HemaCell

Seed Round in 2022
Xueji Bio is a new cell therapy company founded by returnee experts to regenerate hematopoietic lineages (including blood cells and immune cells) in vitro, with unique stem cell reprogramming, editing and differentiation technologies. The company's unique iPSC establishment technology and gene targeting technology can quickly establish a platform using platelet cells as a drug delivery carrier.

Energy Singularity

Venture Round in 2022
Energy Singularity is a nuclear fusion technology company dedicated to advancing clean energy solutions. The company specializes in developing controllable nuclear fusion technology, focusing on high-magnetic field, high-parameter, standardized high-temperature superconducting tokamak devices. These innovations have the potential for commercial power generation and are supported by sophisticated operation control software systems. By pursuing these objectives, Energy Singularity aims to contribute to achieving energy freedom for humanity.

WeShine

Series B in 2022
Developer of marketing SaaS platform based on WeChat enterprise. The company mainly provides integrated marketing and media services on Wechat platform and utilize social medial platform to connect potential customers with enterprises through mobile interaction and digital content, enabling clients to broaden their customer base and improve marketing precision.

Guandata

Series C in 2022
Guandata is committed to the philosophy of “AI+BI makes decisions more intelligent” and is committed to providing next-generation data analytics and business intelligence (BI) solutions to new retail, new finance, pan-Internet and integrated group customers.

Modalku

Series C in 2022
Modalku is an online marketplace based in Jakarta, Indonesia for small businesses to acquire loans and for lenders to fund small business loans to earn compelling returns. Its technology-based approach enables borrowers to receive loans for the first time or at lower than market rates, while lenders will earn returns well above that of bank deposits, traditional fixed income products, and life insurance investment-linked products. This marketplace lending model is proven in countries such as USA, UK, China & Singapore.

SceneRay

Series D in 2022
SceneRay Corporation, Limited is a medical device company based in Suzhou, China, specializing in the design, development, and distribution of neuromodulation devices. The company offers a range of products, including a deep brain stimulation system that features an implantable neuro-stimulator, patient controller, and various accessories. Additionally, SceneRay develops spinal cord stimulation and sacral nerve stimulation systems. The team at SceneRay comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, and the company holds numerous patents in this field. Committed to advancing neuromodulation solutions, SceneRay aims to provide patients with high-quality and effective treatments.

Next World Culture

Series A in 2022
Next World Culture is a startup focusing on creating AI-generated virtual humans.

Taichi Graphics

Series A in 2022
Taichi Graphics builds open-source graphics infrastructure and cloud platforms. Taichi programming language is a popular open-source graphics framework of Taichi Graphics.

Qianglian Zhichuang

Series C in 2022
the first high-tech company in China to focus on the treatment of cerebrovascular disease, it has more than four years of product research and development, leading China's cerebrovascular disease intelligence in an all-around way. vertical field of diagnosis and treatment. It has become a well-known brain stroke intelligence diagnosis and treatment platform in China.

Tongxin Medical Equipment

Series D in 2022
Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency

Shoplazza

Series C in 2022
Shoplazza is a provider of cross-border e-commerce solutions, focusing on empowering Chinese brands to establish a global online presence. Founded in 2017 and based in Shenzhen, the company offers an all-in-one e-commerce platform that includes services for website construction and customization, allowing users to create appealing websites without requiring extensive technical skills. By leveraging advanced technology, Shoplazza delivers a reliable and scalable Shopping Cart Software-as-a-Service, enabling merchants to build direct-to-consumer online stores that cater to diverse shopping scenarios. This comprehensive approach helps businesses manage their online operations effectively while driving revenue growth in international markets.

PhaBuilder

Venture Round in 2022
PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes. PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainly uses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future".

Micronano Core

Seed Round in 2022
Micro-nano core is committed to the development and production of the world's leading intelligent IoT AIoT SoC serialized chips, through the world's leading four core technologies: ultra-low-power chip architecture technology (to solve the problem of system standby power consumption), ultra-low power consumption Power consumption closed-loop adaptive near-threshold circuit technology (to solve the problem of chip running power consumption), ultra-low power consumption and high-precision sensor acquisition technology (to solve the problem of high precision and low power consumption of sensor signal acquisition) and high-efficiency embedded AI engine technology (solving the computing power and energy efficiency of embedded AI), creating a general/platform technology system for IoT chips and AIoT serialized chips, enabling IoT products, and significantly improving the low power consumption, low power consumption, and low power consumption of future IoT products High-precision detection and edge AI inference performance.

NeuroXess

Angel Round in 2022
NeuroXess is an invasive brain-computer interface with high-density flexible brain electrodes aimed at brain research and disease diagnosis.

Virtue Diagnostics

Series B in 2022
VIRTUE Diagnostics(Suzhou)Co.,Ltd. develops in vitro diagnostic platform. The company offers technology platforms including clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. VIRTUE Diagnostics(Suzhou)Co.,Ltd. was founded in 2019 and is based in Suzhou, China with a research and development office in Singapore.

SphereEx

Seed Round in 2022
SphereEx builds new distributed data infrastructures, by being fully committed to the open source community, the platform concept, and cutting-edge Big Data technological innovation. Our R&D efforts led to the success of ShardingSphere, a "platform, pluggable, cloud-native" distributed middleware solution ideal for large-scale data and data value-added applications. Our pioneering "Database Plus" and "Database Mesh" concepts are designed to unlock innovative data usage concepts, improve enterprise data applications, and easily respond to complex data scenarios. Following over 5 years of development, the ShardingSphere project has gained more than 13 thousand GitStars on GitHub, involving over 200 contributors, becoming one of the most popular open source projects. In April 2020, ShardingSphere successfully graduated from the Apache Incubator, and became an Apache Software Foundation Top-Level Project. More recently, ShardingSphere has also been recognized as a Cloud Native Computing Foundation (CNCF) Panorama project. To date, ShardingSphere has already been used in more than 160 enterprise and production environments covering the financial, logistics, O2O, internet & cloud computing fields, to help achieve enterprise digital transformation.

Atom Bioscience

Series C in 2022
Atom Bioscience is a healthcare company based in Zhenjiang, China, that specializes in the research and development of new drugs aimed at treating metabolic diseases and cancers. Founded in 2012, the company focuses on conditions such as Non-Alcoholic SteatoHepatitis (NASH), gout, diabetes, and colon cancers. By concentrating on the interplay between metabolism and inflammation, Atom Bioscience seeks to provide patients with more effective treatment options for these challenging health issues.

fam.

Pre Seed Round in 2022
fam. is a Private social club on top of NFTs.

Vland

Series A in 2021
Vland is a social interactive cloud platform that provides real-time audio, game, and video technology to create virtual space as a service.

Yoguang Technology

Seed Round in 2021
Seetrum is an electronics manufacturing firm that provides advanced spectroscopy chips, AI algorithms, and smart perception solutions.

Carbon Energy Technology

Series A in 2021
Carbon Energy Technology develops technology for carbon utilization and its commercialization.

Treelab

Series A in 2021
Treelab is a Shanghai-based company founded in 2019 that specializes in developing a productivity tool designed for non-technical users to create customized business systems. The platform enables individuals and organizations to develop personalized software applications without the need for programming skills. Treelab's tool is utilized to build solutions across various domains, including project management, sales customer relationship management (CRM), form collection, and human resource management. By empowering users to create their own software, Treelab aims to streamline business processes and enhance productivity.

Choiceform

Venture Round in 2021
Choiceform is a user experience platform that specializes in online questionnaires, data collection, and analysis. It offers a SaaS application designed for survey and market research services, enabling businesses to gather and interpret data effectively. The platform employs an innovative online survey model that enhances the accuracy and completeness of data, making it a valuable tool for market research, consulting, advertising, and marketing purposes. By focusing on user experience, Choiceform assists firms in making informed decisions based on reliable insights.

Recurrent.ai

Venture Round in 2021
Recurrent.ai is a Chinese company that provides AI-enabled corporate services to improve sales efficiency. Through a full set of self-study engine sales dialogue analysis system, it helps companies to transfer sales, customer service and customer dialogue from voice to text, providing full machine quality inspection and sales efficiency optimization. Core functions such as customer portrait records, fully automatic generation of big data dialogue analysis reports, help companies reduce time and labor costs, increase sales conversion rate, and effectively drive decision-making.

Vico Medical

Series B in 2021
Wuhan Vickor Medical Technology Co., Ltd. develops medical devices for cardiovascular and cerebrovascular diseases. It offers atrial shunt, puncture system puncture needle, nano membrane patent foramen ovale occlude, nano membrane patent foramen ovale occlude (single riveting), and delivery system sheath and steel cable products. Wuhan Vickor Medical Technology Co., Ltd. was founded in 2018 and is based in Wuhan, China.

TUNGEE

Series B in 2021
Guangzhou Tungee Technology Co.,Ltd., a software as a service (SaaS) company, develops intelligent sales cloud platform. It provides leads mining, business opportunity engagement, customer relationship management, and order analysis for enterprises. The company offers Tungee intelligent sales cloud platform , outbound leads, inbound leads, engage, cloud-based call center, intelligent call, and CRM products. It also offers Tungee galaxy, prophecy, and discernment solutions. Guangzhou Tungee Technology Co.,Ltd. was founded in 2016 and is based in Panyu, China.

Dangsheng New Materials

Series A in 2021
Dangsheng New Material is a high-performance fiber material developer and a high-tech enterprise dedicated to the development, production and sales of high-performance fiber materials. It has realized the production of China's only high-performance anti-virus and biochemical barrier protective clothing made of a single material. . Dangsheng New Materials provides a series of medical disposable protective products, including protective clothing, isolation clothing, protective shoe covers and other supplies.

QianDao App

Series B in 2021
QianDao App develops blind box toy and garage kit trading software designed for youth. Users can order customize toys according to their personal preferences on the platform this company developed. The products mainly include Happy Train and Wedding Flower Girl series, providing a community for Garage Kit followers and collectors in China. The company was founded in 2019 and is headquartered in Putuo District, Shanghai, China.

Red Way Technology

Seed Round in 2021
Red Way Technology is a privacy and data security service provider focused on data and public security, and intelligent voice analysis.

Beijing Sudo Technology

Series A in 2021
Beijing Sudo Technology provides privacy protection technical services from the perspective of systematic comprehensive engineering.

SyMap Medical

Series E in 2021
SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.

Laifu Technology

Series A in 2021
Laifu Technology is an intelligent middle-station for firms, through digital transformation with the help of software, and customer service.

Transcenta

Post in 2021
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company specializing in the research, development, and manufacturing of antibody-based therapeutics. Founded in 2019 and headquartered in Suzhou, China, Transcenta has additional facilities in major cities including Shanghai, Hangzhou, and Beijing, as well as in Waltham, Massachusetts, and Princeton, New Jersey. The company was formed through the merger of HJB and MabSpace Biosciences and focuses on developing innovative antibodies aimed at treating various conditions. Currently, Transcenta is advancing nine therapeutic antibody molecules targeting oncology and select non-oncology indications, including bone and kidney disorders.

Quanzhi Technology

Series B in 2021
Quanzhi Technology is a data security provider of knowledge-application data and API risk monitoring systems of enterprise data security.

Duoning Biotech

Series C in 2021
Shanghai Duoning Biotechnology Co., Ltd. specializes in the development of serum-free, personalized, and chemically defined cell culture media tailored for the biopharmaceutical industry. Established in 2005, the company focuses on creating basic media, feed media, and cell therapy media, while also offering services for personalized media development and cell culture process optimization. Duoning Biotech employs international animal cell culture concepts and leverages extensive process development experience to provide customized solutions, including commissioned formula production. Its product offerings include various media types, such as S1, S2, S3, S3-CD, S4, and specialized feed media designed to support the growth and maintenance of new animal cells in research and therapeutic applications. The company is headquartered in Shanghai, China.

Neurophth

Series C in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Hejian

Venture Round in 2021
Hejian Industrial Software is a high-performance industrial software and solution provider. With EDA (Electronic Design Automation) as the first breakthrough direction, it is committed to helping semiconductor chip companies solve the severe challenges they face in the process of innovation and development. Challenges and key issues.

KingstronBio

Series C in 2021
KingstronBio manufactures artificial heart valves and annuloplasty rings.

ComGen Biopharmaceutical

Series A in 2021
Kangjing Bio focuses on the research and development of innovative drugs for the immunotherapy of autoimmune diseases and tumors. A round of financing of nearly 100 million yuan has been completed. This round of financing was jointly led by Sequoia China and Yahui Investment, followed by Fuchuang Investment and Renyou Investment. For this transaction, Hejun Capital and Chenrui Capital acted as financial advisors. This round of financing will be mainly used for phase I clinical trials of complement inhibitors under research on new targets, the advancement of other pipeline drugs, and the further consolidation of the application of innovative drug research and development platforms based on the complement system.

ThinkingData

Series C in 2021
Thinking Data is a public opinion analysis service platform focusing on the game industry, providing the world's leading natural language processing and text mining technology. Users can obtain comprehensive and real-time player behavior data, player feedback and product public opinion to optimize the product experience, realize lean operations, and use data to drive user and revenue growth. In September 2016, ThinkingGame was awarded a Series A round of financing, and the investor was Anchor Capital.

Weijian Technology

Series A in 2021
Weijian Technology is a building intelligent robotics product company for the construction industry through robots, IoT, and AI algorithms.

Positive Sequence Biology

Series A in 2021
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Edge Medical Robotics

Series C in 2021
Edge Medical Robotics, Inc. is a company that specializes in designing and developing advanced surgical equipment. Founded on May 4, 2017, and based in Longgang, Shenzhen, China, the company is dedicated to researching and promoting cutting-edge medical technology. Its mission focuses on enhancing surgical safety and treatment efficacy, aiming to elevate the overall standards of healthcare. Through a commitment to excellence and precision in product development, Edge Medical Robotics strives to contribute positively to the improvement of social health outcomes.

Huanju Technology

Series A in 2021
Huanju Technology (main company: Shenzhen Artisan Network Technology Co., Ltd.) is an audio and video marketing technology service provider focusing on the financial industry, committed to providing financial institutions with audio and video marketing technology products, audio and video content and comprehensive marketing solutions. After years of accumulation, Huanju has become the leading all-stop service provider in the financial industry.

Genki Forest

Venture Round in 2021
Genki Forest is a beverage company with Internet genes which specializes in making sugar-free and low-calorie products.